BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Omran Z, H Dalhat M, Abdullah O, Kaleem M, Hosawi S, A Al-Abbasi F, Wu W, Choudhry H, Alhosin M. Targeting Post-Translational Modifications of the p73 Protein: A Promising Therapeutic Strategy for Tumors. Cancers (Basel) 2021;13:1916. [PMID: 33921128 DOI: 10.3390/cancers13081916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kukita A, Sone K, Kaneko S, Kawakami E, Oki S, Kojima M, Wada M, Toyohara Y, Takahashi Y, Inoue F, Tanimoto S, Taguchi A, Fukuda T, Miyamoto Y, Tanikawa M, Mori-uchino M, Tsuruga T, Iriyama T, Matsumoto Y, Nagasaka K, Wada-hiraike O, Oda K, Hamamoto R, Osuga Y. The Histone Methyltransferase SETD8 Regulates the Expression of Tumor Suppressor Genes via H4K20 Methylation and the p53 Signaling Pathway in Endometrial Cancer Cells. Cancers 2022;14:5367. [DOI: 10.3390/cancers14215367] [Reference Citation Analysis]
2 Kadhim Salim N, Hasan Mohammed Ali S, Mahdi Al-Sudani I. Chromogenic in Situ-Hybridization of HPV16/18 DNA in Relation to the Over-Expressed Protein of P73-Gene in Tissues from a Group of Thyroid Carcinoma. Arch Razi Inst 2022;77:967-75. [PMID: 36618305 DOI: 10.22092/ARI.2022.357622.2075] [Reference Citation Analysis]
3 Chen Y. Identification of the Potential Correlation between Tumor Protein 73 and Head and Neck Squamous Cell Carcinoma. Dis Markers 2022;2022:6410113. [PMID: 35756491 DOI: 10.1155/2022/6410113] [Reference Citation Analysis]
4 Cai B, Hsu Y, Yeh F, Lin Y, Lu R, Yu S, Shaw J, Wu M, Tsai Y, Lin Y, Bai Z, Shih Y, Hsu Y, Liao R, Kuo W, Hsu C, Lien C, Chen C. P63 and P73 Activation in Cancers with p53 Mutation. Biomedicines 2022;10:1490. [DOI: 10.3390/biomedicines10071490] [Cited by in F6Publishing: 1] [Reference Citation Analysis]